HAG
AGN

HighPoint Advisor Group’s Allergan plc AGN Stock Holding History

HighPoint Advisor Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,584
Closed -$304K – 411
2019
Q4 		$304K Buy
1,584
+117
+8% +$21.1K 0.06% 266
2019
Q3 		$266K Sell
1,467
-87
-6% -$14.2K 0.06% 264
2019
Q2 		$252K Sell
1,554
-239
-13% -$33.1K 0.06% 270
2019
Q1 		$253K Buy
1,793
+19
+1% +$2.75K 0.06% 274
2018
Q4 		$244K Buy
1,774
+125
+8% +$20.5K 0.06% 265
2018
Q3 		$309K Buy
1,649
+69
+4% +$12.7K 0.08% 219
2018
Q2 		$291K Buy
1,580
+119
+8% +$19.1K 0.08% 236
2018
Q1 		$249K Buy
+1,461
New +$245K 0.07% 271
2017
Q4 		– Sell
-1,142
Closed -$200K – 320
2017
Q3 		$200K Buy
1,142
+64
+6% +$14.9K 0.06% 266
2017
Q2 		$261K Hold
1,078
– – 0.08% 230
2017
Q1 		$261K Buy
1,078
+43
+4% +$10K 0.08% 230
2016
Q4 		$254K Sell
1,035
-162
-14% -$33.6K 0.08% 236
2016
Q3 		$239K Buy
1,197
+35
+3% +$8.55K 0.08% 235
2016
Q2 		$292K Buy
+1,162
New +$268K 0.1% 207

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighPoint Advisor Group's AGN Position: Q1 2020 in Review

HighPoint Advisor Group sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,584 shares — an estimated $304K sold.

HighPoint Advisor Group first reported a position in AGN in Q2 2016 and held it in 14 quarters. The position peaked at $309K in Q3 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • HighPoint Advisor Group reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • HighPoint Advisor Group sold 1,584 Allergan plc shares in Q1 2020, an estimated $304K.
  • HighPoint Advisor Group first reported a position in Allergan plc in Q2 2016 and held it in 14 quarters.
  • HighPoint Advisor Group's Allergan plc position peaked at $309K in Q3 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on HighPoint Advisor Group's 13F filing for Q1 2020, filed 27 Apr 2020.